PNC Financial Services Group
ACOR

PNC Financial Services Group’s Acorda Therapeutics ACOR Stock Holding History

PNC Financial Services Group’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2
Closed – – 4094
2020
Q1 		$0 Sell
2
-1
-33% -$197 ﹤0.01% 4108
2019
Q4 		$1K Sell
3
-18
-86% -$4.54K ﹤0.01% 3921
2019
Q3 		$7K Buy
21
+15
+250% +$8.15K ﹤0.01% 3681
2019
Q2 		$5K Sell
6
-4
-40% -$4.92K ﹤0.01% 3756
2019
Q1 		$16K Hold
10
– – ﹤0.01% 3457
2018
Q4 		$18K Sell
10
-5
-33% -$10.9K ﹤0.01% 3356
2018
Q3 		$35K Hold
15
– – ﹤0.01% 3220
2018
Q2 		$51K Buy
15
+2
+15% +$6.12K ﹤0.01% 2976
2018
Q1 		$38K Buy
13
+5
+63% +$15K ﹤0.01% 3128
2017
Q4 		$21K Sell
8
-4
-33% -$11.4K ﹤0.01% 3392
2017
Q3 		$35K Buy
12
+3
+33% +$7.9K ﹤0.01% 3119
2017
Q2 		$21K Hold
9
– – ﹤0.01% 3319
2017
Q1 		$21K Buy
9
+2
+29% +$5.76K ﹤0.01% 3279
2016
Q4 		$16K Sell
7
-31
-82% -$73.7K ﹤0.01% 3327
2016
Q3 		$96K Sell
38
-26
-41% -$77.6K ﹤0.01% 2479
2016
Q2 		$196K Buy
64
+52
+433% +$169K ﹤0.01% 2104
2016
Q1 		$37K Buy
12
+3
+33% +$12.5K ﹤0.01% 2966
2015
Q4 		$48K Buy
9
+2
+29% +$8.74K ﹤0.01% 2859
2015
Q3 		$23K Sell
7
-2
-22% -$7.76K ﹤0.01% 3307
2015
Q2 		$36K Buy
9
+2
+29% +$7.73K ﹤0.01% 3215
2015
Q1 		$28K Sell
7
-14
-67% -$64.1K ﹤0.01% 3346
2014
Q4 		$104K Buy
21
+20
+2,000% +$85.8K ﹤0.01% 2458
2014
Q3 		$4K Hold
1
– – ﹤0.01% 3528
2014
Q2 		$4K Sell
1
-4
-80% -$16.3K ﹤0.01% 3378
2014
Q1 		$23K Hold
5
– – ﹤0.01% 2809
2013
Q4 		$19K Sell
5
-1
-17% -$3.9K ﹤0.01% 2816
2013
Q3 		$24K Hold
6
– – ﹤0.01% 2771
2013
Q2 		$23K Buy
+6
New +$24.7K ﹤0.01% 2689

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PNC Financial Services Group's ACOR Position: Q2 2020 in Review

PNC Financial Services Group sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 2 shares.

PNC Financial Services Group first reported a position in ACOR in Q2 2013 and held it in 28 quarters. The position peaked at $196K in Q2 2016. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • PNC Financial Services Group reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • PNC Financial Services Group sold 2 Acorda Therapeutics shares in Q2 2020.
  • PNC Financial Services Group first reported a position in Acorda Therapeutics in Q2 2013 and held it in 28 quarters.
  • PNC Financial Services Group's Acorda Therapeutics position peaked at $196K in Q2 2016.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on PNC Financial Services Group's 13F filing for Q2 2020, filed 7 Aug 2020.